Skip to main content
Veterinary Medicines

CANIDIARIX 200 MG / 33 500 UI / 0,008 MG COMPRIMES PELLICULES POUR CHIENS

Authorised
  • Framycetin sulfate
  • Atropine sulfate monohydrate
  • Sulfaguanidine

Product identification

Medicine name:
CANIDIARIX 200 MG / 33 500 UI / 0,008 MG COMPRIMES PELLICULES POUR CHIENS
Active substance:
  • Framycetin sulfate
  • Atropine sulfate monohydrate
  • Sulfaguanidine
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Framycetin sulfate
    33500.00
    international unit(s)
    /
    1.00
    Tablet
  • Atropine sulfate monohydrate
    0.01
    milligram(s)
    /
    1.00
    Tablet
  • Sulfaguanidine
    200.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA99
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Europeenne De Pharmacotechnie Europhartech
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/0235013 0/1989
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 29/11/2023

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025